Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB: Invitation - Presentation of Sobis Q1 2019 results
On 25 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ)
(http://www.sobi.com/) (Sobi) will publish its report for the fourth
quarter and full year 2018. Financial analysts and media are invited
to participate in a telephone conference, which will include a
presentation of the results, on the same day at 10:00 am CET. The
event will be hosted by Sobis CEO and President, Guido Oelkers, and
the presentation will be held in English.
The presentation can be followed live, or afterwards on www.sobi.com.
Slides used in the presentation will be made available on Sobis
website prior to the telephone conference.
To participate in the telephone conference, please call:
SE: +46 8 505 583 69
UK: +44 33 330 090 35
US: +1 646 722 49 57
Click here to go to the live webcast.
After the live event the webcast will be available on-demand via the
At Sobi, we are transforming the lives of people affected by rare
diseases. As a specialised international biopharmaceutical company,
we provide sustainable access to innovative therapies in the areas of
haematology, immunology and specialty care. We bring something rare
to rare diseases - a belief in the strength of focus, the power of
agility and the potential of the people we are dedicated to serving.
The hard work and dedication of our approximately 1050 employees
around the globe has been instrumental in our success across Europe,
North America, the Middle East, Russia and North Africa, leading to
total revenues of SEK 9.1 billion in 2018. Sobis share (STO:SOBI) is
listed on Nasdaq Stockholm. You can find more information about Sobi
For more information please contact
Media relations/Investor Investor relations
Linda Holmström, Senior Jörgen Winroth, Senior IR Advisor
+46 708 734 095 +1 347 224 0819, +1 212 579 0506
Paula Treutiger, Head of
Communications & Investor
+46 733 666 599
Swedish Orphan Biovitrum AB (publ)
Postal address SE-112 76 Stockholm, Sweden
Phone: 46 8 697 20 00 www.sobi.com